F
Frank Sandmann
Researcher at University of London
Publications - 49
Citations - 699
Frank Sandmann is an academic researcher from University of London. The author has contributed to research in topics: Medicine & Economic evaluation. The author has an hindex of 9, co-authored 37 publications receiving 302 citations. Previous affiliations of Frank Sandmann include Erasmus University Rotterdam & Public Health England.
Papers
More filters
Journal ArticleDOI
Quarantine and testing strategies in contact tracing for SARS-CoV-2: a modelling study.
Billy J Quilty,Samuel Clifford,Joel Hellewell,Timothy W Russell,Adam J. Kucharski,Stefan Flasche,W. John Edmunds,Katherine E. Atkins,Anna M Foss,Naomi R. Waterlow,Kaja Abbas,Rachel Lowe,Carl A. B. Pearson,Sebastian Funk,Alicia Rosello,Gwenan M. Knight,Nikos I Bosse,Simon R Procter,Georgia R. Gore-Langton,Alicia Showering,James D Munday,Katharine Sherratt,Thibaut Jombart,Emily Nightingale,Yang Liu,Christopher I Jarvis,Graham F. Medley,Oliver J. Brady,Hamish Gibbs,David Simons,Jack Williams,Damien C. Tully,Sophie Meakin,Kevin van Zandvoort,Fiona Yueqian Sun,Mark Jit,Petra Klepac,Matthew Quaife,Rosalind M Eggo,Frank Sandmann,Akira Endo,Akira Endo,Kiesha Prem,Kiesha Prem,Sam Abbott,Rosanna C. Barnard,Yung Wai D. Chan,Megan Auzenbergs,Amy Gimma,C. Julian Villabona-Arenas,Nicholas G Davies +50 more
TL;DR: In this paper, the authors compared the performance of testing with either PCR or lateral flow antigen (LFA) tests at the end of quarantine and daily LFA testing without quarantine, against the current 14-day quarantine strategy.
Journal ArticleDOI
The potential health and economic value of SARS-CoV-2 vaccination alongside physical distancing in the UK: a transmission model-based future scenario analysis and economic evaluation.
Frank Sandmann,Frank Sandmann,Nicholas G Davies,Anna Vassall,W. John Edmunds,Mark Jit,Mark Jit,Fiona Yueqian Sun,C. Julian Villabona-Arenas,Emily Nightingale,Alicia Showering,Gwenan M. Knight,Katharine Sherratt,Yang Liu,Kaja Abbas,Sebastian Funk,Akira Endo,Joel Hellewell,Alicia Rosello,Rachel Lowe,Matthew Quaife,Amy Gimma,Oliver J. Brady,Jack Williams,Simon R Procter,Rosalind M Eggo,Yung Wai Desmond Chan,James D Munday,Rosanna C. Barnard,Georgia R. Gore-Langton,Nikos I Bosse,Naomi R. Waterlow,Charlie Diamond,Timothy W Russell,Graham F. Medley,Stefan Flasche,Katherine E. Atkins,Kiesha Prem,David Simons,Megan Auzenbergs,Damien C. Tully,Christopher I Jarvis,Kevin van Zandvoort,Sam Abbott,Carl A. B. Pearson,Thibaut Jombart,Sophie Meakin,Anna M Foss,Adam J. Kucharski,Billy J Quilty,Hamish Gibbs,Samuel Clifford,Petra Klepac +52 more
TL;DR: The model findings highlight the substantial health and economic value of introducing SARS-CoV-2 vaccination and the net monetary values of physical distancing scenarios may be negative from societal perspective if the daily national economy losses are persistent and large.
Journal ArticleDOI
Quantifying the economic cost of antibiotic resistance and the impact of related interventions: rapid methodological review, conceptual framework and recommendations for future studies
Mark Jit,Mark Jit,Mark Jit,Dorothy Hui Lin Ng,Nantasit Luangasanatip,Nantasit Luangasanatip,Frank Sandmann,Frank Sandmann,Katherine E. Atkins,Katherine E. Atkins,Julie V. Robotham,Julie V. Robotham,Koen B. Pouwels,Koen B. Pouwels,Koen B. Pouwels +14 more
TL;DR: Quantifying the economic cost of resistance will require greater rigour and innovation in the use of existing methods to design studies that accurately collect relevant outcomes and further research into new techniques for capturing broader economic outcomes.
Journal ArticleDOI
Measuring the effects of COVID-19-related disruption on dengue transmission in southeast Asia and Latin America: a statistical modelling study
Yuyang Chen,Naizhe Li,José Lourenço,Li Wang,Bernard Cazelles,Lu Dong,Bingying Li,Yang Liu,Mark Jit,Nikos I Bosse,Sam Abbott,Raman Velayudhan,Annelies Wilder-Smith,Hua-Yong Tian,Oliver J. Brady,Simon R Procter,Kerry L. M. Wong,Joel Hellewell,Nicholas G Davies,Christopher I Jarvis,Ciara McCarthy,Graham F. Medley,Sophie Meakin,Alicia Rosello,Emilie Finch,Rachel Lowe,Carl A. B. Pearson,Samuel Clifford,Billy J Quilty,Stefan Flasche,Hamish Gibbs,Lloyd A. C. Chapman,Katherine E. Atkins,David M. Hodgson,Rosanna C. Barnard,Timothy W Russell,Petra Klepac,Y Jafari,Rosalind M Eggo,Paul Mee,Matthew Quaife,Akira Endo,Sebastian Funk,Stéphane Hué,Adam J. Kucharski,W. John Edmunds,Kathleen M. O’Reilly,Rachael Pung,Christian Julian Villabona-Arenas,Amy Gimma,Kaja Abbas,Kiesha Prem,Gwenan M. Knight,Fiona Yueqian Sun,William J. Waites,James D Munday,Mihaly Koltai,Frank Sandmann,Damien C. Tully +58 more
TL;DR: It is estimated that 0·72 million (95% CI 0·12–1·47) fewer dengue cases occurred in 2020 potentially attributable to COVID-19-related disruption, even after taking into account other drivers of d Dengue cycles including climatic and host immunity.
Journal ArticleDOI
Estimating the Hospital Burden of Norovirus-Associated Gastroenteritis in England and Its Opportunity Costs for Nonadmitted Patients.
Frank Sandmann,Frank Sandmann,Laura Shallcross,Natalie Adams,David J. Allen,David J. Allen,Pietro G Coen,Annette Jeanes,Zisis Kozlakidis,Lesley Larkin,Fatima Wurie,Julie V. Robotham,Mark Jit,Mark Jit,Sarah R Deeny +14 more
TL;DR: Since the introduction of rotavirus vaccination in England in July 2013, norovirus has become the second-largest contributor of inpatient gastroenteritis, preventing 57800 patients from being admitted annually, translating into 6300 quality-adjusted life years.